70
Participants
Start Date
November 11, 2023
Primary Completion Date
November 11, 2025
Study Completion Date
November 11, 2025
Validity, Reliability and Adaptation
The Hoehn \& Yahr Scale (HDS) and the Unified Parkinson's Disease Rating Scale (UPDRS) will be used for the clinical evaluation and disease staging of the individuals included in the study. In addition to the PDQoL-7 questionnaire, the 'Short Form-36' and 'Parkinson's Disease Questionnaire-39' questionnaires will be administered to patients to assess concurrent validity. Since at least 5-10 times the number of items in the questionnaire (7 items) must include at least 5-10 times the number of participants in order to perform factor analysis, a pretest of the questionnaire will be applied to individuals with PD with at least 35-70 participants. To determine the test-retest reliability, the PDQoL7 questionnaire will be administered again to the same patients after 2 weeks.
RECRUITING
Niğde Ömer Halisdemir University, Niğde
RECRUITING
Ankara Medipol University, Ankara
RECRUITING
Gazi University, Ankara
Gazi University
OTHER
Nigde Omer Halisdemir University
OTHER